U.S. Medical Equipment Stock News

In the past quarter, Lyft, Inc. reported second‑quarter 2026 sales of US$1,843.54 million and net income of US$50.29 million, both higher than a year earlier, while also adding airline executive Ben Minicucci to its board and avoiding a proposed 10% rideshare tax in Anaheim’s tourism district. Together, stronger profitability, fresh board-level operating experience from the airline sector, and relief from a potential local tax highlight how Lyft is tightening its operations while benefiting...

FedEx Freight Holding Company shares closed at US$146.42, up 2.4% after the latest earnings, as investors leaned into the freight story rather than flinched at the headline numbers. The real flashpoint in this report is profit pressure. Quarterly net income of US$51 million for the latest fiscal quarter compares with US$251 million in the same quarter a year earlier, and trailing net margin over the past year sits at 10.4% versus 15.5% in the prior year. That short term squeeze is exactly...

WaterBridge Infrastructure entered this earnings release after a strong 90 day share run, then the stock slipped about 2.5% as the market cooled on the story. The headline is simple. Revenue reached about US$217.8 million in Q2 and earnings per share landed a little over US$0.09. For a stock often discussed as a high growth midstream water platform with valuation questions, the real swing factor this quarter is profitability. WaterBridge Infrastructure is now reporting positive earnings after...

EMCOR Group has been a strong stock over the past several years, yet current valuation checks suggest the market price may still sit below what its intrinsic value estimate implies. After a very large 5 year return, the key issue is whether today's price fairly reflects the business the company has become. Over the last 5 years, EMCOR Group has delivered a very large total return of about 5.8x, which puts extra focus on whether recent gains have already captured its fundamentals. Growing...

StoneX Group stock just absorbed a 12% hit in a single session, yet the earnings story behind that move is far more complicated than a simple miss or disappointment. You are looking at a financial services platform that produced Q3 net income of US$127.9m and diluted earnings per share of US$1.00, alongside a trailing P/E of 15.4x that sits below the cited US market and industry averages. The market is reacting strongly to a single day of trading. The key question is whether that pullback...

In early August 2026, Fiserv, Borderless.xyz and other partners announced new collaborations with Mastercard that expand its merchant services reach, embed Mastercard Crypto Credential into cross-border stablecoin payment flows, and enhance premium travel and lifestyle benefits on co‑branded cards. Together with Mastercard’s recent earnings beat and ongoing share repurchases, these partnerships highlight how the company is weaving its network, standards and value‑added services into emerging...

In the second quarter of 2026, Better Home & Finance Holding reported a net loss of US$30.59 million, improved from a US$36.27 million loss a year earlier, and announced that long-time CEO Vishal Garg had stepped down, with board member Daniel Lewis taking over as Interim CEO. Alongside this leadership change, Better amended its broker agreement so that Intuit Credit Karma, rather than Better, will offer Credit Karma’s 140 million-strong U.S. consumer base access to Home Equity Line of...

ICF International (ICFI) just paired its second quarter earnings release with a new US$35 million energy efficiency contract from Entergy Louisiana. Both updates give you fresh data on profit trends and contract momentum. See our latest analysis for ICF International. The recent Entergy Louisiana contract and the second quarter earnings update appear to have coincided with stronger interest in ICF International, with the share price at US$85.31 and a 90 day share price return of 22.55%...

In the second quarter of 2026, Pfizer reported revenue of US$15,034 million, up from US$14,653 million a year earlier, but swung from net income of US$2,910 million to a net loss of US$248 million after recording US$4.30 billion in non-cash intangible asset impairments. Despite these impairments, Pfizer raised its 2026 revenue guidance midpoint to US$61.50 billion and highlighted encouraging late-stage pipeline progress, including positive Phase 3 results for its vitiligo therapy...

DraftKings stock has had a tough run over the past few years, yet some valuation checks now point to it trading on the cheaper side of the sector. That mix of weak long term returns and pockets of apparent value is what current investors are trying to make sense of. DraftKings shareholders have seen the stock decline 59.4% over the past 5 years, which sets a cautious backdrop for any argument that the current share price already discounts the main risks. Expectations around how profitably...

FactSet Research Systems (FDS) has drawn fresh attention after expanding its collaboration with RepRisk AG, selecting the firm as its preferred partner for sustainable investing products and business conduct risk data across multiple investment workflows. See our latest analysis for FactSet Research Systems. Set against these partnerships and leadership changes, FactSet Research Systems has seen a 22.79% 90 day share price return, even as the 1 year total shareholder return has declined...

Trustmark (TRMK) has drawn fresh attention after a busy late July update. The bank reported second quarter and first half 2026 results, affirmed a quarterly dividend, disclosed higher net charge offs, and outlined recent share repurchases. See our latest analysis for Trustmark. Trustmark's recent earnings beat, higher dividend visibility and completion of its buyback program have come alongside a 90 day share price return of 7.11% and a year to date share price return of 22.56%. The 1 year...

In the second quarter of 2026, Accel Entertainment, Inc. reported higher year-over-year sales, revenue, and net income, while also repurchasing approximately 500,000 shares for US$5.6 million and ending the period with about US$255 million in cash, net debt of roughly US$318 million, and an undrawn US$300 million credit facility. Management emphasized a disciplined, returns-focused capital allocation approach, highlighting the company’s capacity to fund organic investment, pursue...

Why Norwegian Cruise Line Holdings Stock Is Back In Focus Norwegian Cruise Line Holdings (NCLH) has drawn renewed attention after a recent analyst note flagged softer near term demand and heavier promotional activity, despite the company posting stronger quarterly earnings and operating metrics. See our latest analysis for Norwegian Cruise Line Holdings. The recent analyst comments on softer near term demand sit against a mixed share price picture for Norwegian Cruise Line Holdings. The 90...

Vanda Pharmaceuticals stock barely budged after earnings, up about 0.5% to around US$5, even though the quarter underscored how hard the current build out is hitting the income statement. The headline is simple: revenue held around US$50.5m while the Q2 net loss widened to US$62.5m as spending on late stage trials and new launches weighed heavily. Investors came into this print after a tough stretch, with the stock down about 20% over the past month. The key question now is how long the...

Fastly stock has delivered a sharp rerating over the past year, yet the current valuation checks point to a company that screens as expensive rather than a clear bargain. Fastly has returned 204.0% over the past year, which puts more pressure on today’s buyers to justify the higher entry price. The company’s role in Experian’s Agent Trust ecosystem can support growth expectations around AI related traffic, while any disappointment in monetizing this kind of partnership may weigh heavily on...

Traders nudged Editas Medicine up about 5% today, which looks like a cautious, rather than euphoric, vote on a tricky set of numbers. The stock came into this report under pressure over the past month, so even a small relief move matters. The headline is margin pain meeting revenue progress. Total revenue for the quarter sat at US$11.89 million while the company still reported a loss with basic earnings per share at US$0.15 in the red. The real question now is whether this mix justifies...

Rigetti Computing (RGTI) is back in focus after its second quarter 2026 earnings report, which combined strong year over year revenue growth with a wider loss and several high profile quantum computing partnership updates. See our latest analysis for Rigetti Computing. Rigetti Computing’s share price has fallen 30% year to date, even after an 11% 7 day share price return following the earnings release and recent government and HPE partnership announcements, while the 3 year total shareholder...

Leggett & Platt recently reported its second-quarter 2026 results, with sales of US$999.7 million and net income of US$47.1 million, both lower than a year earlier, and declared a third-quarter dividend of US$0.05 per share payable on August 24, 2026. The combination of softer revenue and earnings for both the quarter and first half of 2026 highlights ongoing pressure on profitability despite the continued dividend payout. With second-quarter sales and earnings declining year over year,...

Sandisk stock closed down 6.8% at US$1,258.58, capping a tough month for holders after a double digit slide over 30 days. That reaction sits awkwardly next to a quarter where revenue hit US$8.97b and non GAAP earnings per share jumped to US$39.25, both ahead of management guidance. The real focus is not today’s drop but what this earnings release suggests about the multi year arc. Sandisk has moved from losses to a full year of profit and now trades on a trailing P/E of 16.4x, while a...

NASB Financial slipped about 1% today, even though the latest quarter showed the kind of earnings power many regional banks would welcome. Basic earnings per share for Q3 landed at roughly US$1.48 on revenue of about US$24.8 million, contributing to a trailing 12 month P/E of 8.4x that currently sits below the broader US banks sector and wider market. For short term traders the red screen might stand out. For longer term investors the focus is on the sustained profitability and the relatively...

Expedia Group just served up the kind of quarter that usually earns a celebration, yet the stock slipped 4.1% to about US$306 after the report. The gap between the reaction and the results is striking. Revenue for Q2 came in at US$4.3b and adjusted EBITDA margin reached 25.9%, with management confident enough to lift full year margin expansion targets. Investors came into this print after a strong three month run in the stock. Today’s move suggests profit taking and nerves, while the earnings...

Allient just ripped 19.3% higher in a single session, and that kind of move always raises the same question: Is this emotion or earnings talking? Coming into the print, the stock was already on a tear over the past quarter, and the valuation looked stretched on a P/E that sat well above peers. The headline this time is profit power. Quarterly basic earnings per share reached about US$0.62 on revenue of roughly US$153.8m, with trailing net income roughly doubling over the past year and net...

BeOne Medicines (ONC) stock is in focus after the company reported second quarter 2026 earnings and raised its full year revenue and GAAP operating income guidance on 5 August 2026. See our latest analysis for BeOne Medicines. The latest earnings surprise and higher 2026 guidance appear to be feeding into BeOne Medicines' momentum, with a 30-day share price return of 6.75% and a 1-year total shareholder return of 10.56%. The 3-year total shareholder return of 66.63% reflects a stronger long...